The Yin and Yang of arterial inflammation

被引：33

作者：

Mills, R ^{[1
]}

Bhatt, DL ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2004年 / 44卷 / 01期

关键词：

D O I：

10.1016/j.jacc.2004.04.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：50 / 52

页数：3

共 21 条

[1] Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina [J].

Anguera, I ;

Miranda-Guardiola, F ;

Bosch, X ;

Filella, X ;

Sitges, M ;

Marín, J ;

Betriu, A ;

Sanz, G .

AMERICAN HEART JOURNAL, 2002, 144 (05) :811-817

[2] Need to test the arterial inflammation hypothesis [J].

Bhatt, DL ;

Topol, EJ .

CIRCULATION, 2002, 106 (01) :136-140

[3] Soluble CD40 ligand levels indicate lipid accumulation in carotid atheroma -: An in vivo study with high-resolution MRI [J].

Blake, GJ ;

Ostfeld, RJ ;

Yucel, EK ;

Varo, N ;

Schönbeck, U ;

Blake, MA ;

Gerhard, M ;

Ridker, PM ;

Libby, P ;

Lee, RT .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (01) :E11-E14

[4] Interleukin-18 and the risk of coronary heart disease in European men -: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) [J].

Blankenberg, S ;

Luc, G ;

Ducimetière, P ;

Arveiler, D ;

Ferrières, J ;

Amouyel, P ;

Evans, A ;

Cambien, F ;

Tiret, L .

CIRCULATION, 2003, 108 (20) :2453-2459

[5] Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein [J].

Chew, DP ;

Bhatt, DL ;

Robbins, MA ;

Mukherjee, D ;

Roffi, M ;

Schneider, JP ;

Topol, EJ ;

Ellis, SG .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (06) :672-674

[6] Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention [J].

Chew, DP ;

Bhatt, DL ;

Robbins, MA ;

Penn, MS ;

Schneider, JP ;

Lauer, MS ;

Topol, EJ ;

Ellis, SG .

CIRCULATION, 2001, 104 (09) :992-997

[7] Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial [J].

Chung, ES ;

Packer, M ;

Lo, KH ;

Fasanmade, AA ;

Willerson, JT .

CIRCULATION, 2003, 107 (25) :3133-3140

[8] Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women - A randomized trial [J].

Esposito, K ;

Pontillo, A ;

Di Palo, C ;

Giugliano, G ;

Masella, M ;

Marfella, R ;

Giugliano, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (14) :1799-1804

[9] Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease [J].

Fichtlscherer, S ;

Rosenberger, G ;

Walter, DH ;

Breuer, S ;

Dimmeler, S ;

Zeiher, AM .

CIRCULATION, 2000, 102 (09) :1000-1006

[10] Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease [J].

Fichtlscherer, S ;

Breuer, S ;

Heeschen, C ;

Dimmeler, S ;

Zeiher, AM .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (01) :44-49

← 1 2 3 →